[go: up one dir, main page]

SE8701437D0 - DIAGNOSTIC PROCEDURE IN VITRO AND MEDICINES THAT CAN BE USED BY THE PROCEDURE - Google Patents

DIAGNOSTIC PROCEDURE IN VITRO AND MEDICINES THAT CAN BE USED BY THE PROCEDURE

Info

Publication number
SE8701437D0
SE8701437D0 SE8701437A SE8701437A SE8701437D0 SE 8701437 D0 SE8701437 D0 SE 8701437D0 SE 8701437 A SE8701437 A SE 8701437A SE 8701437 A SE8701437 A SE 8701437A SE 8701437 D0 SE8701437 D0 SE 8701437D0
Authority
SE
Sweden
Prior art keywords
procedure
vitro
elastase
value
taken
Prior art date
Application number
SE8701437A
Other languages
Swedish (sv)
Other versions
SE8701437L (en
Inventor
Tom Gustaf Per Saldeen
Rolf Kenth Sigvard Wallin
Original Assignee
Tom Gustaf Per Saldeen
Rolf Kenth Sigvard Wallin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tom Gustaf Per Saldeen, Rolf Kenth Sigvard Wallin filed Critical Tom Gustaf Per Saldeen
Priority to SE8701437A priority Critical patent/SE8701437L/en
Publication of SE8701437D0 publication Critical patent/SE8701437D0/en
Priority to JP63503362A priority patent/JPH02503033A/en
Priority to EP88903441A priority patent/EP0353242A1/en
Priority to PCT/SE1988/000167 priority patent/WO1988008134A1/en
Priority to AU15961/88A priority patent/AU1596188A/en
Publication of SE8701437L publication Critical patent/SE8701437L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Method for the in vitro diagnostication of diseases associated with fibrin(ogen)olysis and/or pathological elastase activity, characterized in that a sample taken from a patient and containing fibrinopeptides is subjected to quantification of at least one elastase induced B beta 14(+/-2) - 45(+/-3) fibrinopeptide(s). The value thus obtained is compared with a normal value for healthy individuals, and that if the value obtained is higher than said normal value the patient from whom the sample has been taken is classed as being diseased. The assay method provides a way of demonstrating the presence of free elastase activity in samples taken from patients. Furthermore, novel antibody preparations as well as novel elastase induced B beta 14(+/-2) - 45(+/-3) fibrinopeptide preparations are described which may be employed in the said method.
SE8701437A 1987-04-06 1987-04-06 IN VITRO DIAGNOSTIC PROCEDURE AND MEASURES THAT CAN BE USED IN THE PROCEDURE SE8701437L (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8701437A SE8701437L (en) 1987-04-06 1987-04-06 IN VITRO DIAGNOSTIC PROCEDURE AND MEASURES THAT CAN BE USED IN THE PROCEDURE
JP63503362A JPH02503033A (en) 1987-04-06 1988-04-05 In vitro diagnostic methods and means useful therefor
EP88903441A EP0353242A1 (en) 1987-04-06 1988-04-05 METHOD AND MEANS FOR DIAGNOSTIC DETECTION OF ELASTASE DERIVED B-beta FIBRINOPEPTIDES
PCT/SE1988/000167 WO1988008134A1 (en) 1987-04-06 1988-04-05 METHOD AND MEANS FOR DIAGNOSTIC DETECTION OF ELASTASE DERIVED Bbeta-FIBRINOPEPTIDES
AU15961/88A AU1596188A (en) 1987-04-06 1988-04-05 Method and means for diagnostic detection of elastase derived Bbeta-fibrino peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701437A SE8701437L (en) 1987-04-06 1987-04-06 IN VITRO DIAGNOSTIC PROCEDURE AND MEASURES THAT CAN BE USED IN THE PROCEDURE

Publications (2)

Publication Number Publication Date
SE8701437D0 true SE8701437D0 (en) 1987-04-06
SE8701437L SE8701437L (en) 1988-10-07

Family

ID=20368117

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701437A SE8701437L (en) 1987-04-06 1987-04-06 IN VITRO DIAGNOSTIC PROCEDURE AND MEASURES THAT CAN BE USED IN THE PROCEDURE

Country Status (5)

Country Link
EP (1) EP0353242A1 (en)
JP (1) JPH02503033A (en)
AU (1) AU1596188A (en)
SE (1) SE8701437L (en)
WO (1) WO1988008134A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124107A (en) * 1988-06-10 2000-09-26 Merck & Co., Inc. Assay for marker of human polymorphonuclear leukocyte elastase activity
DE68925923T2 (en) * 1988-06-10 1996-11-14 Merck & Co Inc Antigens of the only fibrinogen cleavage site by elastase
RU2195660C1 (en) * 2001-06-07 2002-12-27 Савина Лидия Васильевна Method of diagnosing hyperelastasemy
US20100203565A1 (en) * 2005-03-22 2010-08-12 Astrazeneca Ab Peptide Fingerprint from the Degradation of Elastin by HNE
WO2017083515A2 (en) * 2015-11-10 2017-05-18 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
DE3400434A1 (en) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg DETERMINATION OF FIBRINE WITH FIBRINE-SPECIFIC ANTIBODY

Also Published As

Publication number Publication date
AU1596188A (en) 1988-11-04
JPH02503033A (en) 1990-09-20
SE8701437L (en) 1988-10-07
WO1988008134A1 (en) 1988-10-20
EP0353242A1 (en) 1990-02-07

Similar Documents

Publication Publication Date Title
DE3771185D1 (en) OPTICAL DETECTOR FOR THE SIMULTANEOUS DETECTION OF HEARTBEAT AND TORAXIAL MOVEMENT.
DE69110098D1 (en) Test strips for the visual determination of the blood glucose concentration.
FI890591A7 (en) Coeastia and device for performing biological analyses
AU613881B2 (en) Automated patient sample analysis instrument
DK552684D0 (en) DESULPHATO HIRUDINES AND THEIR PREPARATION AND USE
DE69005840D1 (en) Analytical element for the examination of the whole blood.
FI89060B (en) FRAMEWORK FOR THE PROCESSING OF THERAPEUTIC ANALYSIS
DE69019886D1 (en) Catheters and instruments for extracorporeal circulation.
ATE54826T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING THYMUS EXTRACT FRACTIONS.
DE68928728D1 (en) DIAGNOSIS OF RETINOBLASTOMA
DE3783966D1 (en) REAGENTS FOR THE EXAMINATION OF PERIODENTAL DISEASES.
ATE84877T1 (en) METHODS FOR CRYSTAL MORPHOLOGICAL BLOOD AND URINAL ANALYSIS, FOR EARLY DIAGNOSIS AND FOR THE MANUFACTURE OF MEDICINES.
DE3870405D1 (en) TEST DEVICE FOR DETERMINING OCCULT BLOOD AND GLUCOSE.
DE3583875D1 (en) METHOD FOR PRODUCING SPHERICAL WHOLE BLOOD ERYTHROCYTES AND FIXING THEREOF.
SE8701437D0 (en) DIAGNOSTIC PROCEDURE IN VITRO AND MEDICINES THAT CAN BE USED BY THE PROCEDURE
DE3879085D1 (en) SNRNP-A-ANTIGEN AND FRAGMENTS THEREOF.
FI895215A7 (en) Method for determining the biological activity of antithrombin III and reagent therefor
DE3852625D1 (en) Vectors and compounds for the expression of zymogen forms of human protein C.
DE69505376D1 (en) ALPHA B CRYSTALLIN FOR USE IN DIAGNOSIS AND THERAPY OF AUTOIMMUNE DISEASES, ESPECIALLY MULTIPLE SCEROSIS
DE3853560D1 (en) Analytical element for whole blood testing.
ATE108906T1 (en) METHOD OF DETERMINING THE BEHAVIOR OF DRUGS IN LIVING THINGS.
DE3850933D1 (en) Anticoagulant protein PP4-X, its production and use.
FI914160A7 (en) Analysis and treatment of autoimmune diseases
DE3575732D1 (en) USE OF GONADOLIBERIN AND GONADOLIBERINAGONISTS FOR PRODUCING A PHARMACEUTICAL PREPARATION.
AU3065789A (en) Clinical testing, monitoring and pharmaceutical compositions for treatment of auto-immune diseases